Daniel Menold
Vice President, Finance at CymaBay Therapeutics, Inc. (CBAY)
Daniel Menold has filed 10 insider reports with the SEC since January 2021, as vice President and finance at CymaBay Therapeutics, Inc. (CBAY). Daniel Menold made no open-market purchases or sales in the last 12 months. In the latest filing, on January 17, 2024, Daniel Menold sold 10,000 shares of CymaBay Therapeutics, Inc. (CBAY) for $236K at an average of $23.58.
- Filings
- 10
- Companies
- 1
- Bought on market
- None
- Sold on market
- $967K
Companies where Daniel Menold is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Vice President, Finance | 0 | $967K | Jan 17, 2024 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Jan 16, 2024-$236KCBAYMenold Daniel sold $235,806 worth of shares (10,000 units at $23.58) and exercised 10,000 shares at a strike of $4.05Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Dec 15, 2023-$473KCBAYMenold Daniel sold $472,646 worth of shares (21,497 units at $21.99) and exercised 21,497 shares at a strike of $6.39Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Nov 15, 2023CBAYMenold Daniel exercised 17,500 shares at a strike of $3.45 and sold 0 sharesForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Oct 16, 2023CBAYMenold Daniel exercised 17,500 shares at a strike of $3.45 and sold 0 sharesForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Sep 15, 2023CBAYSEC Form 4: Menold Daniel exercised 16,545 shares at a strike of $1.73 and sold 0 sharesForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Aug 15, 2023CBAYSEC Form 4: Menold Daniel exercised 15,500 shares at a strike of $5.10 and sold 0 sharesForm 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Aug 9, 2023-$259KCBAYSEC Form 4: Menold Daniel exercised 20,945 shares at a strike of $5.00 and sold $258,744 worth of shares (20,945 units at $12.35)Form 4Exercise or conversion of a derivativeOpen-market sale10b5-1 plan
- Jan 25, 2023CBAYSEC Form 4 filed by Menold DanielForm 4Grant or award
- Jan 25, 2022CBAYSEC Form 4 filed by Menold DanielForm 4Grant or award
- Jan 6, 2021CBAYSEC Form 4 filed by Daniel MenoldForm 4Grant or award
Compare Daniel Menold with
- Daniel Menold vs Caroline M Loewy1 shared
- Daniel Menold vs Charles McWherter1 shared
- Daniel Menold vs Eric Lefebvre1 shared
- Daniel Menold vs Janet Dorling1 shared
- Daniel Menold vs Harish Shantharam1 shared
- Daniel Menold vs Klara Dickinson1 shared
Questions about Daniel Menold
- What is Daniel Menold's role at CymaBay Therapeutics, Inc.?
- Daniel Menold reports to the SEC as vice President and finance at CymaBay Therapeutics, Inc. (CBAY), according to the latest filing on January 17, 2024.
- Has Daniel Menold bought or sold stock recently?
- The most recent open-market sale was on January 16, 2024: sold 10,000 shares of CymaBay Therapeutics, Inc. (CBAY) for $236K at an average of $23.58.
- How do I get alerts when Daniel Menold files?
- Follow Daniel Menold on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Daniel Menold (SEC CIK 0001705745). Totals count each trade once, skipping amendments whose original is on file, from Jan 28, 2021 on. View on SEC EDGAR · Get this as JSON